Technology Roundup – Ant Group’s IPO valuation increases again to $280B, China set to approve its own tech protection law Technology
Healthcare Roundup – Remdesivir has little effect on mortality, Gilead Science lands WHO distinction for remdesivir Life Science
Technology Roundup – FCC Chairman Pai says he’ll revisit social-media law, Big Tech sentiment gets shaky Technology
Technology Roundup – Apple’s iPhone 12 suppliers positively mentioned at JPMorgan, Carriers look to solidify customer base with iPhone deals Technology
Healthcare Roundup – Trump administration expands collaboration with AstraZeneca on COVID-19 antibody drug, Moderna makes headway in bringing COVID vaccine to European market Life Science
Technology Roundup – Only 10% of Piper survey respondents want Apple’s new iPhone, Ant Group’s $35B IPO delayed by Chinese regulator scrutiny Technology
Healthcare Roundup – First case of COVID-19 reinfection confirmed in the U.S.; Relief/NeuroRx reports encouraging Aviptadil data Life Science
Healthcare Roundup – Lilly/Innovent rituximab injection OK’d in China; BioNTech, Pfizer announce rolling submission for COVID-19 vaccine candidate Life Science
Technology Roundup – Chinese funds targeting Ant IPO draw $9B, Microsoft is making work from home a permanent option Technology
Technology Roundup – AT&T, Nokia, Ericsson chosen for Defense Dept. 5G testing; Google Assistant now can open, search mobile apps Technology
Healthcare Roundup – Late-stage study of Emergent Bio’s COVID-19 plasma, Lilly’s baricitinib shows incremental benefit Life Science
Healthcare Roundup – Regeneron +2.3% after Trump praises drug, Aprea on go with early-stage study with APR-548 Life Science
Technology Roundup – Facebook now removing all QAnon content, Nokia, Tampere University team up Technology
